Pyrrolidine derivatives

Details Pyrrolidine derivatives Pyrrolidine derivatives

2007-03-13

2007-03-13

Shameem, Golam M. M. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S530000, C548S539000, C548S541000, C548S542000, C514S424000, C514S425000

Reexamination Certificate

active

10881427

ABSTRACT:
The present invention relates to pyrrolidine derivatives useful as inhibitors of metalloproteases, e.g. zinc proteases, and which are effective in treating disease states associated with vasoconstriction.

REFERENCES:
patent: 6541638 (2003-04-01), Aebi et al.
patent: 6790860 (2004-09-01), Aebi et al.
patent: 0 182 213 (1986-05-01), None
patent: 0 333 175 (1989-09-01), None
patent: 0 528 678 (1993-02-01), None
patent: 0 747 381 (1996-12-01), None
patent: WO 97/30046 (1997-08-01), None
patent: WO 98/08814 (1998-03-01), None
patent: WO 98/08815 (1998-03-01), None
Yanagisawa, M. et al. Nature (Mar. 31, 1998), 332 (6/63), pp. 411-415.
Xu, D., et al., Cell (1994) vol. 78 pp. 473-485.
Oefner, et al., J. Mol. Biol. (2000) 296, pp. 341-349.
Chemical Abstract, “Preparation of 3-pyrrolidinylthio-1-aza-bicyclo ‘3.2.0’ hept-2-ene-2-carboxylic . . . ” JP 06 263761 (Fujisowa Pharmaceutical Co., Ltd. JP), Sep. 20, 1994.
Chemical Abstract, “Synthesis and antimicrobial evaluation of 3-(substituted)pyrrolidine cephalosporins”, (Yoo, Ji-Seak et al., JP) (1999).

Affiliated with

Also associated with

Rating

Pyrrolidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrolidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3793086